Cargando…
Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174395/ https://www.ncbi.nlm.nih.gov/pubmed/35461397 http://dx.doi.org/10.1007/s13300-022-01263-7 |
| _version_ | 1784722225199316992 |
|---|---|
| author | Di Loreto, Chiara Minarelli, Viviana Nasini, Giovanni Norgiolini, Roberto Del Sindaco, Paola |
| author_facet | Di Loreto, Chiara Minarelli, Viviana Nasini, Giovanni Norgiolini, Roberto Del Sindaco, Paola |
| author_sort | Di Loreto, Chiara |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9174395 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91743952022-06-09 Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria Di Loreto, Chiara Minarelli, Viviana Nasini, Giovanni Norgiolini, Roberto Del Sindaco, Paola Diabetes Ther Correction Springer Healthcare 2022-04-23 2022-06 /pmc/articles/PMC9174395/ /pubmed/35461397 http://dx.doi.org/10.1007/s13300-022-01263-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Di Loreto, Chiara Minarelli, Viviana Nasini, Giovanni Norgiolini, Roberto Del Sindaco, Paola Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria |
| title | Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria |
| title_full | Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria |
| title_fullStr | Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria |
| title_full_unstemmed | Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria |
| title_short | Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria |
| title_sort | correction to: effectiveness in real world of once weekly semaglutide in people with type 2 diabetes: glucagon-like peptide receptor agonist naïve or switchers from other glucagon-like peptide receptor agonists: results from a retrospective observational study in umbria |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174395/ https://www.ncbi.nlm.nih.gov/pubmed/35461397 http://dx.doi.org/10.1007/s13300-022-01263-7 |
| work_keys_str_mv | AT diloretochiara correctiontoeffectivenessinrealworldofonceweeklysemaglutideinpeoplewithtype2diabetesglucagonlikepeptidereceptoragonistnaiveorswitchersfromotherglucagonlikepeptidereceptoragonistsresultsfromaretrospectiveobservationalstudyinumbria AT minarelliviviana correctiontoeffectivenessinrealworldofonceweeklysemaglutideinpeoplewithtype2diabetesglucagonlikepeptidereceptoragonistnaiveorswitchersfromotherglucagonlikepeptidereceptoragonistsresultsfromaretrospectiveobservationalstudyinumbria AT nasinigiovanni correctiontoeffectivenessinrealworldofonceweeklysemaglutideinpeoplewithtype2diabetesglucagonlikepeptidereceptoragonistnaiveorswitchersfromotherglucagonlikepeptidereceptoragonistsresultsfromaretrospectiveobservationalstudyinumbria AT norgioliniroberto correctiontoeffectivenessinrealworldofonceweeklysemaglutideinpeoplewithtype2diabetesglucagonlikepeptidereceptoragonistnaiveorswitchersfromotherglucagonlikepeptidereceptoragonistsresultsfromaretrospectiveobservationalstudyinumbria AT delsindacopaola correctiontoeffectivenessinrealworldofonceweeklysemaglutideinpeoplewithtype2diabetesglucagonlikepeptidereceptoragonistnaiveorswitchersfromotherglucagonlikepeptidereceptoragonistsresultsfromaretrospectiveobservationalstudyinumbria |